Ăterna Zentaris CEO to Take Part in Panel Discussion on Cancer Therapy at Upcoming RBC Capital Markets Healthcare Conference in New York on March 3

Tuesday, February 23, 2010 General News
Email Print This Page Comment
Font : A-A+

QU╔BEC CITY, Feb. 23 /PRNewswire-FirstCall/ - Ăterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), (the "Company"), a late-stage drug development company specialized

in oncology and endocrinology, today announced that its President and CEO, Juergen Engel, Ph.D., will take part in a panel discussion titled, "Cancer: Improving Treatment through Combination Therapy" at the RBC Capital
Markets Healthcare Conference on Wednesday, March 3, 2010, from 8:00 am to 8:55 am (eastern) in the Holmes I Room of The New York Palace Hotel in New York City.

A live audio webcast of the panel discussion will be available in the Investors section of the Company's website at www.aezsinc.com. A replay of the webcast will also be available on its website for a period of 30 days.

About Ăterna Zentaris Inc.

Ăterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrinology. News releases and additional information are available at www.aezsinc.com.

SOURCE AETERNA ZENTARIS INC.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook